EGLN2 and cancer: We found that PHD1 inhibition partially restored HIF-1α accumulation and activation in docetaxel-treated cancer cells under hypoxic conditions (Fig. 3b–f) and reduced docetaxel-induced cell death (Fig. 5c–f).